Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA.
Cardiovascular Division, Department of Medicine, Women's College Hospital; and Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Canada.
JACC Heart Fail. 2022 Jun;10(6):404-414. doi: 10.1016/j.jchf.2022.02.008. Epub 2022 May 4.
Acute coronary syndrome (ACS) is frequently complicated by evidence of heart failure (HF). Those at highest risk for acute decompensated HF in the setting of ACS (ACS-HF) are older, female, and have preexisting heart disease, type 2 diabetes mellitus, hypertension, and/or kidney disease. The presence of ACS-HF is strongly associated with higher mortality and more frequent readmissions, especially for HF. Low implementation of guideline-directed medical therapy has further complicated the clinical care of this high-risk population. Improved utilization of current therapies, coupled with further investigation of strategies to manage ACS-HF, is desperately needed to improve outcomes in this vulnerable population, and the results of currently ongoing or recently concluded ACS-HF studies in this population are of great interest. In this review, we explore the pathophysiology, epidemiology, risk factors, and outcomes for patients with ACS-HF, and describe both existing evidence for management of this challenging condition and areas requiring further research.
急性冠状动脉综合征(ACS)常伴有心力衰竭(HF)的证据。ACS 患者中急性失代偿性 HF 风险最高的是年龄较大、女性、患有先前存在的心脏病、2 型糖尿病、高血压和/或肾病的患者。ACS-HF 的存在与更高的死亡率和更频繁的再入院率密切相关,尤其是 HF。指南指导的药物治疗的低实施率进一步使这一高危人群的临床护理复杂化。迫切需要更好地利用现有的治疗方法,并进一步研究管理 ACS-HF 的策略,以改善这一脆弱人群的预后,目前正在进行或最近结束的 ACS-HF 研究的结果对此人群具有重要意义。在这篇综述中,我们探讨了 ACS-HF 患者的病理生理学、流行病学、危险因素和结局,并描述了管理这一具有挑战性的疾病的现有证据和需要进一步研究的领域。